By Greg Ryan (December 19, 2013, 6:15 PM EST) -- A week after hitting Boehringer Ingelheim International GmbH with a nearly $1 million penalty for discovery abuses, an Illinois federal judge ruled Wednesday that the drugmaker may be slapped with even more sanctions in multidistrict litigation over its blood thinner Pradaxa.
BII, the German parent of fellow defendant Boehringer Ingelheim Pharmaceuticals Inc., informed U.S. District Judge David Herndon on Monday that it has access to the so-called user share for a former employee, Thorstein Lehr, even though it had previously said the file was unavailable. In addition, it did not keep Lehr's smartphone and computers.
In an order, Judge Herndon found...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!